CRISPR ‘super-soldiers?’ Why we need international gene-editing rules

designer

Within this century, human beings will be capable of changing their genes to modify traits like intelligence, or even instincts like aggression, the renowned physicist Stephen Hawking predicted. Months after his death [in 2018], a scientist in China shocked the world by announcing he had created the world’s first genetically modified human babies – a step towards the future Hawking envisioned.

If governments were to start modifying their populations’ genes on a mass scale to treat genetic ailments such as sickle cell disease, would that pave the way towards the eventual use of this technology for enhancement?

“Oh, that’s going to happen for sure,” says Derya Unutmaz, a Connecticut-based immunologist and principal researcher at Jackson Laboratory. “At the military level you can imagine you want to create super-soldiers who can withstand all kinds of diseases and tough weather and carry hundreds of kilograms”

One way to counter this would be to have a global regulatory system for genetic modification that could prevent or discourage countries from abusing it.

[CRISPR co-creator Jennifer] Doudna says that a big challenge will be to determine how to use the technology responsibly in the context of international science, considering the fact that it is widely available.

Read full, original post: The future of gene editing: ending disease or creating super-soldiers or a master race? Why rules are needed

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion more—to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
images
The never-ending GMO debate: Pros and cons
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.